Autologous platelet-derived wound healing factor promotes angiogenesis via alphavbeta3-integrin expression in chronic wounds
- PMID: 11029516
- DOI: 10.3892/ijmm.6.5.515
Autologous platelet-derived wound healing factor promotes angiogenesis via alphavbeta3-integrin expression in chronic wounds
Abstract
Healing of venous leg ulcers depends on the adhesive interaction and formation of new vascular cells. Angiogenesis on the surface of angiogenic blood vessels requires the vascular integrin alphavbeta3 also known as the vitronectin receptor. Autologous platelet-derived wound healing factor (autologous PDWHF) has been described to regulate the wound healing process by forming granulation tissue in the early healing phase. Here we analysed the influence of autologous PDWHF on the expression of the alphavbeta3 integrin in tissue specimen of venous leg ulcers in comparison with placebo treated controls by using reverse transcriptase-polymerase chain reaction and immunohistochemistry. Our investigations provide evidence that mRNA and protein expression of alphavbeta3 were significantly increased in healing venous leg ulcers after 96 h treatment (p<0.05), whereas the total amount of alphavbeta3 mRNA and protein was not altered in placebo treated patients. In healing leg ulcers the alphavbeta3 integrin was predominantly localized around capillary vessels preferentially at sites of newly formed granulation tissue. Placebo controlled patients displayed no altered expression of the alphavbeta3 integrin in biopsy specimen. These findings suggest that topical autologous platelet-derived wound healing factor influences the process of angiogenesis/revascularization via alphavbeta3 integrin-expression hereby promoting granulation tissue formation in healing leg ulcers.
Similar articles
-
[Questionable effectiveness of autologous platelet growth factors (PDWHF) in treatment of venous ulcers of the leg].Hautarzt. 1999 Dec;50(12):859-65. doi: 10.1007/s001050051000. Hautarzt. 1999. PMID: 10663020 Clinical Trial. German.
-
Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers.J Vasc Surg. 2003 Dec;38(6):1342-8. doi: 10.1016/s0741-5214(03)00908-x. J Vasc Surg. 2003. PMID: 14681639 Clinical Trial.
-
A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report.J Vasc Surg. 1991 Oct;14(4):526-32; discussion 532-6. J Vasc Surg. 1991. PMID: 1920650 Clinical Trial.
-
Wound care in venous ulcers.Phlebology. 2013 Mar;28 Suppl 1:79-85. doi: 10.1177/0268355513477015. Phlebology. 2013. PMID: 23482540 Review.
-
Angiogenesis, vasculogenesis, and induction of healing in chronic wounds.Vasc Endovascular Surg. 2005 Jul-Aug;39(4):293-306. doi: 10.1177/153857440503900401. Vasc Endovascular Surg. 2005. PMID: 16079938 Review.
Cited by
-
Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis.Angiogenesis. 2009;12(2):177-85. doi: 10.1007/s10456-009-9141-9. Epub 2009 Mar 8. Angiogenesis. 2009. PMID: 19267251 Free PMC article. Review.
-
Paracrine stimulation of endothelial cell motility and angiogenesis by platelet-derived deoxyribose-1-phosphate.Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2631-8. doi: 10.1161/ATVBAHA.110.215855. Epub 2010 Sep 30. Arterioscler Thromb Vasc Biol. 2010. PMID: 20884872 Free PMC article.
-
Platelet-rich plasma combined with skin substitute for chronic wound healing: a case report.J Extra Corpor Technol. 2006 Sep;38(3):260-4. J Extra Corpor Technol. 2006. PMID: 17089514 Free PMC article.
-
Platelet alpha-granules: basic biology and clinical correlates.Blood Rev. 2009 Jul;23(4):177-89. doi: 10.1016/j.blre.2009.04.001. Epub 2009 May 17. Blood Rev. 2009. PMID: 19450911 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources